Nova Leap Health Corp. NVLPF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 1,060.29% | -74.24% | -113.77% | 262.21% | -7.71% |
| Total Depreciation and Amortization | 7.81% | 24.56% | 42.70% | 25.98% | 2.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -54.24% | 307.45% | 234.79% | -100.78% | -52.62% |
| Change in Net Operating Assets | -197.55% | -195.11% | -177.25% | -37.72% | -30.41% |
| Cash from Operations | 42.98% | 45.05% | 12.13% | 0.87% | -26.71% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 9.41% | 88.93% | 20.63% | -923.56% | -923.56% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 10.29% | 89.04% | 21.88% | -933.56% | -933.56% |
| Total Debt Issued | -26.60% | -100.00% | -24.41% | -- | -- |
| Total Debt Repaid | -41.39% | -71.03% | -74.84% | 15.80% | 45.48% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -82.51% | -242.36% | -1,470.73% | -1,293.07% | -382.44% |
| Cash from Financing | -76.72% | -178.09% | -134.41% | 206.75% | 195.83% |
| Foreign Exchange rate Adjustments | -158.57% | 279.86% | 247.34% | -126.09% | 975.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -78.81% | 25.75% | -82.26% | -17.11% | -17.76% |